Acquisition Opportunity Dependable Plastics was acquired by Biomerics in July 2022, creating a division focused on interventional medical plastics. This signals a potential cross-sell path into biomedical device manufacturing materials and processes, leveraging Biomerics’ contract manufacturing network.

Medical Device Synergy Post-acquisition alignment with Biomerics Interventional Medical Plastics Division suggests high relevance for customers needing medical-grade plastic parts, cleanroom manufacturing, and regulatory-compliant plastics solutions.

Growth Scale Current revenue range is estimated between $25M and $50M with a modest employee base. Opportunities exist to engage growth-focused buyers seeking scalable plastic manufacturing capabilities and capabilities expansion.

Digital Footprint Presence in digital tooling (WordPress site, SEO plugins, analytics) indicates potential for digital marketing partnerships, lead generation collaborations, and enhanced online content to attract target industrial buyers.

Industry Fit Operating in industrial machinery manufacturing with a plastics focus places them alongside plastics distributors and engineering service firms; comparable peers include mid-market plastics players, suggesting avenues for channel partnerships and co-marketing with similar suppliers.